Invitrogen™ West Nile Virus Matrix Synthetic Peptide

Catalog No.	Quantity
PEP0219	50 μg

Catalog No. PEP0219 Supplier Invitrogen™ Supplier No. PEP0219

Description

Synthetic Peptide

West Nile Virus Matrix Synthetic Peptide, PEP-0219, from Invitrogen.

West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its pre-M form as a heterodimer with the envelope proteins. Cleavage of the pre-M protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin.

Specifications

• Species: Virus
• Purification Method: purified
• Common Name: West Nile Virus Matrix
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Lyophilized: No
• Preservative: 0.02% sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO - research use only
• Storage Buffer: PBS